Technology insight: Image-guided therapies for hepatocellular carcinoma--intra-arterial and ablative techniques (Q33245966)

24 July 2017

1 reference

title

Technology insight: Image-guided therapies for hepatocellular carcinoma--intra-arterial and ablative techniques (English)

1 reference

24 July 2017

Kelvin Hong

1

1 reference

24 July 2017

Christos S Georgiades

series ordinal

2

1 reference

24 July 2017

Jean-Francois H Geschwind

series ordinal

3

1 reference

24 July 2017

1 June 2006

1 reference

Nature Clinical Practice Oncology

24 July 2017

1 reference

24 July 2017

3

1 reference

24 July 2017

6

1 reference

24 July 2017

315-324

1 reference

https://scigraph.springernature.com/pub.10.1038/ncponc0512

24 July 2017

0 references

cites work

Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

Application of poly-lactide-co-glycolide-microspheres in the transarterial chemoembolization in an animal model of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

Treatment of inoperable hepatocellular carcinoma with intrahepatic arterial yttrium-90 microspheres: a phase I and II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

Needle tract seeding after radiofrequency ablation of hepatic tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

Adverse events during radiofrequency treatment of 582 hepatic tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

Treatment of hepatocellular carcinoma: value of percutaneous microwave coagulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

Radiofrequency Ablation in the Treatment of Small Hepatocellular Carcinomas: Comparison of the Radiofrequency Effect With and Without Chemoembolization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

Management of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

Liver resections in cirrhotic patients: a Western experience

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

Chemoembolization for hepatocellular carcinoma: where does the truth lie?

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

Hepatic artery chemoembolization for hepatocellular carcinoma in patients listed for liver transplantation

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

Multimodal image-guided tailored therapy of early and intermediate hepatocellular carcinoma: long-term survival in the experience of a single radiologic referral center

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

Chemoembolization for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

Co-expression of Bcl-2 protein and vascular endothelial growth factor in hepatocellular carcinomas treated by chemoembolization

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

Preparation and characterisation of poly(vinyl alcohol)/cyclodextrin microspheres as matrix for inclusion and separation of drugs.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

Yttrium-90 microspheres for the treatment of hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

Internal radiation therapy for patients with primary or metastatic hepatic cancer: a review

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

Intratumor ethanol injection

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

Factors that predict intrahepatic recurrence of hepatocellular carcinoma in 81 patients initially treated by percutaneous ethanol injection

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

Percutaneous treatment of hepatic neoplasms: A review of current techniques

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

No treatment, resection and ethanol injection in hepatocellular carcinoma: a retrospective analysis of survival in 391 patients with cirrhosis. Italian Cooperative HCC Study Group

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

Radiofrequency thermal ablation of hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

Radiofrequency tissue ablation in the rabbit lung: efficacy and complications

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

Laparoscopic thermal ablation of hepatic neuroendocrine tumor metastases.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

Ex vivo experiment on radiofrequency liver ablation with saline infusion through a screw-tip cannulated electrode

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

Radiofrequency ablation of porcine liver in vivo: effects of blood flow and treatment time on lesion size

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

Percutaneous radiofrequency tissue ablation: does perfusion-mediated tissue cooling limit coagulation necrosis?

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

Lesion progression with time and the effect of vascular occlusion following radiofrequency ablation of the liver.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

Radiofrequency ablation: the experts weigh in.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

Recurrent hepatocellular carcinoma: percutaneous radiofrequency ablation after hepatectomy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

Comparing the outcomes of radiofrequency ablation and surgery in patients with a single small hepatocellular carcinoma and well-preserved hepatic function

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

Risk of tumour seeding after percutaneous radiofrequency ablation for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

Cryosurgery on the Treatment of Hepatic Tumors

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

Ablative therapy for liver tumours

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

World survey on the complications of hepatic and prostate cryotherapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

Thermal ablation for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

Small hepatocellular carcinoma: comparison of radio-frequency ablation and percutaneous microwave coagulation therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

Standards for selecting percutaneous ethanol injection therapy or percutaneous microwave coagulation therapy for solitary small hepatocellular carcinoma: consideration of local recurrence

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

Percutaneous microwave coagulation therapy for patients with small hepatocellular carcinoma: comparison with percutaneous ethanol injection therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

Prognostic factors for survival in patients with hepatocellular carcinoma after percutaneous microwave ablation

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

Interstitial laser photocoagulation under ultrasound guidance of liver tumors: results in 104 treated patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

Laser thermal ablation in the treatment of small hepatocellular carcinoma: results in 74 patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

Hepatocellular carcinoma: evaluation of therapeutic response to interventional procedures

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

Comparison of CT findings with resected specimens after chemoembolization with iodized oil for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

MRI of hepatocellular carcinoma before and after transcatheter chemoembolization

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

Role of diffusion-weighted imaging in estimating tumor necrosis after chemoembolization of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma--a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial. Groupe CHC

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term results

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

Hepatic radiofrequency ablation.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0512

7 January 2021

Identifiers

DOI

10.1038/NCPONC0512

1 reference

Dimensions Publication ID

24 July 2017

0 references

1 reference